Fighting back against brain drain

Western Europe is becoming increasingly dependent on importing talent to address its workforce crisis, but there are signs of resistance to the brain drain. With Nigeria looking to introduce a mandatory domestic five-year service for all doctors, HBI speaks to a global workforce expert to see if this kind of pushback could have any lasting impact.

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.

Interview: Arjan Toor, CEO, Cigna Europe

Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.

Many CEE markets to crash as remittances drop

Private healthcare markets in CEE/Southeast Europe are set to crash this year due to economic contractions at home and abroad, with many countries highly reliant on remittance money from abroad.

FREE BLOG New HBI pipeline tool reveals long-held investments 

Nearly a third of all private equity-owned health care businesses in Europe have been held for at least five years, according to the new HBI Deals Pipeline tool. That suggests many private equity houses are struggling to sell on their investments.

Diaverum enters second new market of 2019

Soon-to-sell global dialysis provider Diaverum has bought an Albanian dialysis provider from investors and the country's dominant healthcare service group, marking its first entry into the small market. We talk to one of the selling party.

Albania’s biggest hospital group corners market

American Hospital of Albania, the country's largest hospital operator, has further consolidated the national market with its acquisition of listed Greek group Hygeia's Tirana hospital for a €1m cash fee and assumption of €29m in liabilities. We talk to the buyer's CEO.

Find Us